• All
  • Manufacturing
  • Marketing
  • Biotech
  • All

    Mylan snared in carcinogen scare with voluntary nizatidine recall

    You’ll want to read this between meetings. Fierce Pharma

    Bayer's 'tumor-agnostic' cancer med Vitrakvi turned away in England, Germany

    Share with your team. Fierce Pharma

    Durect's painkiller gets evenly split decision from expert panel

    So relevant. Fierce Biotech

    Sponsored Ad

    Featured

    Sponsored Ad

    JPM: Watch out, Roche. BioMarin's gene therapy might bleed off the hemophilia A market

    Life Science news you need to know. Fierce Pharma

    JPM: Glaxo's cancer unit, in commercial 'building mode,' gets choosy with M&A

    Have you read this yet? Fierce Pharma

    JPM: Biotech, VC execs on where the industry should look beyond cancer

    Explore recent news. Fierce Biotech

    SOURCE EXPLORER Updates

    To Niche or Not to Niche: The Life Sciences Marketing Question

    To Niche or Not to Niche: The Life Sciences Marketing Question

    Sponsored Ad

    The Importance of Protecting PI’s Prior to Launch

    The Importance of Protecting PI’s Prior to Launch

    When to use War Games in Life Sciences

    When to use War Games in Life Sciences

    New Commercial Models in the Pharma Industry

    New Commercial Models in the Pharma Industry

    Pharma Companies Killing It with Social Media

    Pharma Companies Killing It with Social Media

    View all Updates